| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K30748066 |
| PharmacoGx | BRD-K30748066 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MAZ | CTRPv2 | pan-cancer | AAC | 0.49 | 0.0003 |
| mRNA | UTP11 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0003 |
| mRNA | NDUFAF4 | CTRPv2 | pan-cancer | AAC | 0.43 | 0.0003 |
| mRNA | TYRO3 | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0003 |
| mRNA | OR9A4 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0003 |
| mRNA | COMMD9 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0003 |
| mRNA | EFR3B | CTRPv2 | pan-cancer | AAC | 0.47 | 0.0003 |
| mRNA | MAGOH | CTRPv2 | pan-cancer | AAC | 0.42 | 0.0003 |
| mRNA | LILRB2 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0003 |
| mRNA | GPR84 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.0003 |
